About
Calimmune is a clinical-stage biotechnology company developing gene-modified cell therapies aimed at treating and potentially curing HIV/AIDS and other immune-related diseases.
Explore Calimmune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.